277 related articles for article (PubMed ID: 28166401)
21. Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles.
Wang R; Hu X; Wu S; Xiao H; Cai H; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Nov; 9(11):3200-8. PubMed ID: 22954154
[TBL] [Abstract][Full Text] [Related]
22. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
[TBL] [Abstract][Full Text] [Related]
24. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
[TBL] [Abstract][Full Text] [Related]
26. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
27. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
Qin X; Fang L; Chen F; Gou S
Eur J Med Chem; 2017 Sep; 137():167-175. PubMed ID: 28586717
[TBL] [Abstract][Full Text] [Related]
28. Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects.
Intini FP; Zajac J; Novohradsky V; Saltarella T; Pacifico C; Brabec V; Natile G; Kasparkova J
Inorg Chem; 2017 Feb; 56(3):1483-1497. PubMed ID: 28102676
[TBL] [Abstract][Full Text] [Related]
29. Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates.
Duong HT; Huynh VT; de Souza P; Stenzel MH
Biomacromolecules; 2010 Sep; 11(9):2290-9. PubMed ID: 20831272
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
31. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
[TBL] [Abstract][Full Text] [Related]
32. Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.
Kabolizadeh P; Engelmann BJ; Pullen N; Stewart JK; Ryan JJ; Farrell NP
J Biol Inorg Chem; 2012 Jan; 17(1):123-32. PubMed ID: 21918844
[TBL] [Abstract][Full Text] [Related]
33. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.
Cerri S; Piccolini VM; Santin G; Bottone MG; De Pascali SA; Migoni D; Iadarola P; Fanizzi FP; Bernocchi G
Neurotoxicol Teratol; 2011; 33(2):273-81. PubMed ID: 20883777
[TBL] [Abstract][Full Text] [Related]
34. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
35. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation.
Ashoo P; Yousefi R; Nabavizadeh SM; Aseman MD; Paziresh S; Ghasemi A; Saboury AA
Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879
[TBL] [Abstract][Full Text] [Related]
36. Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(II) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction.
Marqués-Gallego P; Gamiz-Gonzalez MA; Fortea-Pérez FR; Lutz M; Spek AL; Pevec A; Kozlevčar B; Reedijk J
Dalton Trans; 2010 Jun; 39(21):5152-8. PubMed ID: 20419195
[TBL] [Abstract][Full Text] [Related]
37. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
Min Y; Li J; Liu F; Yeow EK; Xing B
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
[TBL] [Abstract][Full Text] [Related]
38. Cellular processing of platinum anticancer drugs.
Wang D; Lippard SJ
Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
[TBL] [Abstract][Full Text] [Related]
39. Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.
Zhang ZL; Zhao CL; Chen Q; Xu K; Qiao X; Xu JY
Eur J Med Chem; 2018 Jul; 155():434-444. PubMed ID: 29908438
[TBL] [Abstract][Full Text] [Related]
40. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]